Seroprevalence of anti-SARS-CoV-2 IgG antibodies in children with household exposure to adults with COVID-19: Preliminary findings.


Journal

Pediatric pulmonology
ISSN: 1099-0496
Titre abrégé: Pediatr Pulmonol
Pays: United States
ID NLM: 8510590

Informations de publication

Date de publication:
06 2021
Historique:
revised: 11 01 2021
received: 20 08 2020
accepted: 15 01 2021
pubmed: 21 1 2021
medline: 2 6 2021
entrez: 20 1 2021
Statut: ppublish

Résumé

Weather and the susceptibility of children to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is still a debated question and currently a hot topic, particularly in view of important decisions regarding opening schools. Therefore, we performed this prospective analysis of anti-SARS-CoV-2 immunoglobulin G (IgG) antibodies in children with known household exposure to SARS-CoV-2 and compared their IgG status with the other adults exposed to the index case in the same household. A total of 30 families with a documented COVID-19 index case were included. A total of 44 out of 80 household contacts (55%) of index patients had anti SARS-CoV-2 IgG antibodies. In particular, 16/27 (59,3%) adult partners had IgG antibodies compared with 28/53 (52,3%) of pediatric contacts (p > .05). Among the pediatric population, children ≥5 years of age had a similar probability of having SARS-CoV-2 IgG antibodies (21/39, 53.8%) compared to those less than 5 years old (7/14, 50%) (p > .05). Adult partners and children also had a similar probability of having SARS-CoV-2 IgG antibodies. Interestingly, 10/28 (35.7%) of children and 5/27 (18.5%) of adults with SARS-CoV-2 IgG antibodies were previously diagnosed as COVID-19 cases. Our study shows evidence of a high rate of IgG antibodies in children exposed to SARS-CoV-2. This report has public health implications, highlighting the need to establish appropriate guidelines for school openings and other social activities related to childhood.

Identifiants

pubmed: 33470561
doi: 10.1002/ppul.25280
pmc: PMC8014267
doi:

Substances chimiques

Antibodies, Viral 0
Immunoglobulin G 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1374-1377

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

JAMA. 2020 Jul 21;324(3):259-269
pubmed: 32511692
JAMA Pediatr. 2020 Sep 1;174(9):902-903
pubmed: 32745201
Pediatr Pulmonol. 2021 Jun;56(6):1374-1377
pubmed: 33470561
N Engl J Med. 2020 Jul 9;383(2):187-190
pubmed: 32356945
JAMA. 2020 Aug 11;324(6):603-605
pubmed: 32644129
Lancet Child Adolesc Health. 2020 Nov;4(11):807-816
pubmed: 32758454
MMWR Morb Mortal Wkly Rep. 2020 Aug 07;69(31):1023-1025
pubmed: 32759921
Emerg Infect Dis. 2020 Oct;26(10):2465-2468
pubmed: 32673193
Lancet Child Adolesc Health. 2020 Sep;4(9):653-661
pubmed: 32593339
Front Pediatr. 2020 Apr 30;8:215
pubmed: 32426311
Aging Clin Exp Res. 2020 Aug;32(8):1613-1620
pubmed: 32529595

Auteurs

Danilo Buonsenso (D)

Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario, Rome, Italy.
Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, Rome, Italy.
Center for Global Health Research and Studies, Università Cattolica del Sacro Cuore, Roma, Italia.

Piero Valentini (P)

Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario, Rome, Italy.
Center for Global Health Research and Studies, Università Cattolica del Sacro Cuore, Roma, Italia.

Cristina De Rose (C)

Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario, Rome, Italy.

Davide Pata (D)

Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario, Rome, Italy.

Dario Sinatti (D)

Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario, Rome, Italy.

Domenico Speziale (D)

Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Rosalba Ricci (R)

Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Angelo Carfì (A)

Geriatrics Department, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.

Francesco Landi (F)

Geriatrics Department, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.

Vittoria Ferrari (V)

Medicine and Surgery, Catholic University of Rome, Rome, Italy.

Flavio De Maio (F)

Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Ivana Palucci (I)

Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Maurizio Sanguinetti (M)

Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, Rome, Italy.
Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Michela Sali (M)

Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, Rome, Italy.
Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH